Patent details

EP3337485 Title: CRYSTALLINE FORMS OF IBRUTINIB

Basic Information

Publication number:
EP3337485
PCT Application Number:
IB2016054823
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168367159
PCT Publication Number:
WO2017029586
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF IBRUTINIB
French Title of Invention:
FORMES CRISTALLINES D'IBRUTINIB
German Title of Invention:
KRISTALLINE FORMEN VON IBRUTINIB
SPC Number:

Dates

Filing date:
10/08/2016
Grant date:
17/03/2021
EP Publication Date:
27/06/2018
PCT Publication Date:
23/02/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/03/2021
EP B1 Publication Date:
17/03/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/08/2021
Expiration date:
10/08/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/03/2021
 
 

Name:
Sun Pharmaceutical Industries Ltd
Address:
Sun House, Plot N°. 201 B/1 Western Express Highway Goregoan (E), 400063 Mumbai, Maharashtra, India (IN)

Inventor

1

Name:
BHOGALA, Bala Krishna Reddy
Address:
India (IN)

2

Name:
SANTRA, Ramkinkar
Address:
India (IN)

3

Name:
KHANDURI, Chandra Has
Address:
India (IN)

Priority

Priority Number:
2558DE2015
Priority Date:
19/08/2015
Priority Country:
India (IN)

Classification

IPC classification:
A61K 31/519; A61P 35/00; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
202111
Publication date:
17/03/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages